NCT05712746 - Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure. | Biotech Hunter

Enrollment

1,600

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions

Heart Failure

Interventions

DRUG

Samtasu for I.V. infusion

"Drug: 8 mg/vial or 16mg/vial~Dosage and Administration:~The usual adult dosage of tolvaptan sodium phosphate is 16 mg once daily and intravenously infused over 1 hour."

Trial Locations (1)

540-0021

RECRUITING

Pharmacovigilance Department, Osaka